Circulation Research
Circulation Research
5 years ago

Mitochondrial Oxidative Stress Reduces the Immunopotency of Mesenchymal Stromal Cells in Adults with Coronary Artery Disease.

Yan Burelle, Ines Colmegna, Dominique Shum-Tim, Alexanne Cuillerier, Maximilien Lora, Ursula Stochaj, Ozge Kizilay Mancini, Reggie C Hamdy, Marc J Servant
Rationale: Mesenchymal stromal cells (MSCs) are promising therapeutic strategies for coronary artery disease (CAD), however, donor-related variability in cell quality is a main cause of discrepancies in preclinical studies. In vitro, MSCs from individuals with CAD have reduced ability to suppress activated T-cells. The mechanisms underlying the altered immunomodulatory capacity of MSCs in the context of atherosclerosis (ATH) remain elusive. Objective: The aim of this study was to assess the role of mitochondrial dysfunction in the impaired immunomodulatory properties of MSCs from ATH patients. Methods and Results: Adipose tissue-derived MSCs were isolated from ATH (n=38) and Non ATH (n=42) donors. MSCs:CD4(+) T-cell suppression, was assessed in allogeneic co-culture systems. Compared to Non ATH-, ATH-MSCs displayed higher levels of both intracellular (p=0.006) and mitochondrial (p=0.03) reactive oxygen species (ROS) reflecting altered mitochondrial function. The increased mitochondrial ROS levels of ATH-MSCs promoted a phenotypic switch characterized by enhanced glycolysis and an altered cytokine secretion (interleukin-6 (IL-6) p<0.0001, IL-8/CXCL8 p=0.04, and monocyte chemoattractant protein-1 (MCP-1/CCL2) p=0.01). Furthermore, treatment of ATH-MSCs with the ROS scavenger N-acetyl-L-cysteine (NAC) reduced the levels of IL-6, IL-8/CXCL8, and MCP-1/CCL2 in the MSC secretome and improved MSCs immunosuppressive capacity (p=0.03). Conclusions: An impaired mitochondrial function of ATH-MSCs underlies their altered secretome, and reduced immunopotency. Interventions aimed at restoring the mitochondrial function of ATH-MSCs improve their in vitro immunosuppressive ability, and may translate into enhanced therapeutic efficiency.

Publisher URL: http://doi.org/10.1161/CIRCRESAHA.117.311400

DOI: 10.1161/CIRCRESAHA.117.311400

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.